Table 3.
Patient characteristics of samples included in VA microbiome analysis.
Colon AC (n = 13 a ) | PDAC (n = 14) | p-value | |
---|---|---|---|
Cancer stage | |||
Local malignancy | 13 (92.9%) | 12 (85.7%) | >0.999 b |
Metastatic malignancy | 1 (7.1%) | 2 (14.3%) | |
Age (years), median (range) | 69.0 (57.0–90.0) | 64.5 (49.9–89.0) | 0.394 c |
Sex | |||
Male | 4 (30.8%) | 9 (64.3%) | 0.128 b |
Female | 9 (69.2%) | 5 (35.7%) | |
Diabetes | |||
Yes | 3 (23.1%) | 7 (50.0% | 0.237 b |
No | 10 (76.9%) | 7 (50.0% |
n, number. AC, adenocarcinoma; PDAC, pancreatic ductal adenocarcinoma.
Four out of 13 patients were excluded from the analysis due to low bacterial hits.
Fisher’s exact test.
Mann–Whitney U test.